FCM
PRCT icon

Frontier Capital Management’s Procept Biorobotics PRCT Stock Holding History

Frontier Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.6M Buy
1,091,528
+481,671
+79% +$12.1M 0.23% 165
2026
Q1 		$15.3M Buy
609,857
+375,677
+160% +$10.6M 0.16% 192
2025
Q4 		$7.37M Buy
234,180
+128,712
+122% +$4.27M 0.08% 258
2025
Q3 		$3.76M Sell
105,468
-313,190
-75% -$14.3M 0.03% 278
2025
Q2 		$24.1M Buy
418,658
+203,602
+95% +$11.5M 0.22% 166
2025
Q1 		$12.5M Sell
215,056
-10,296
-5% -$703K 0.14% 200
2024
Q4 		$18.1M Buy
+225,352
New +$19.3M 0.17% 176

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Frontier Capital Management's PRCT Position: Q2 2026 in Review

Frontier Capital Management increased its Procept Biorobotics (PRCT) stake by 79% in Q2 2026, buying an estimated $12.1M and bringing the position to 1,091,528 shares worth $24.6M. The position accounts for 0.23% of the portfolio, ranked #165.

Frontier Capital Management first reported a position in PRCT in Q4 2024 and has held it in 7 quarters since. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Frontier Capital Management held 1,091,528 shares of Procept Biorobotics worth $24.6M as of Q2 2026.
  • Frontier Capital Management bought 481,671 Procept Biorobotics shares in Q2 2026, an estimated $12.1M.
  • Procept Biorobotics made up 0.23% of Frontier Capital Management's portfolio in Q2 2026, its #165 holding.
  • Frontier Capital Management first reported a position in Procept Biorobotics in Q4 2024 and has held it in 7 quarters since.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Frontier Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.